Detection of EGFR T790M in EGFR activating mutation-positive advanced non-small cell lung cancer (NSCLC): Comparison between two assays on circulating tumour (ct)DNA

被引：0
|
作者：
Charpentier, S. [1 ]
Herbreteau, G. [1 ]
Vallee, A. [1 ]
Henaff, D. [2 ]
Grewis, L. [2 ]
Denis, M. G. [3 ]
机构：
[1] CHU Nantes, Hotel Dieu, Biochim Plateforme Genet Canc, Nantes, France
[2] ID Solut, Grabels, France
[3] CHU Nantes, Hotel Dieu, Biochem Dept, Nantes, France
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1354P
引用
收藏
页码：S868 / S868
页数：1
相关论文
共 50 条
  • [31] Third-generation inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancer
    Shuhang Wang
    Shundong Cang
    Delong Liu
    Journal of Hematology & Oncology, 9
  • [32] Third-generation inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancer
    Wang, Shuhang
    Cang, Shundong
    Liu, Delong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 9
  • [33] Poor Prognosis With Coexistence Of EGFR T790M Mutation And Common EGFR-Activating Mutation In Non- Small Cell Lung Cancer
    Gao, Xuejuan
    Zhao, Yanfeng
    Bao, Yi
    Yin, Wei
    Liu, Liyu
    Liu, Ruchuan
    Yu, Zhengquan
    Zhou, Xiao
    Shuai, Jianwei
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 9621 - 9630
  • [34] Role of T790M Mutation in EGFR-TKI Rechallenge for Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer
    Zhang, Qiu-Yi
    Ke, E-E
    Deng, Wei
    Niu, Fei-Yu
    Zhao, Ning
    Su, Jian
    Chen, Zhi-Hong
    Yang, Jin-Ji
    Xu, Chong-Rui
    Yan, Hong-Hong
    Wu, Yi-Long
    Zhou, Qing
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S271 - S271
  • [35] Mixed Response of Non-Small Cell Lung Cancer Harboring the EGFR T790M Mutation to Osimertinib
    Shinno, Y.
    Goto, Y.
    Sato, J.
    Morita, R.
    Matsumoto, Y.
    Murakami, S.
    Kanda, S.
    Horinouchi, H.
    Fujiwara, Y.
    Yamamoto, N.
    Ohe, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2145 - S2145
  • [36] Osimertinib in Japanese patients with EGFR T790M mutation-positive advanced non-small-cell lung cancer: AURA3 trial
    Akamatsu, Hiroaki
    Katakami, Nobuyuki
    Okamoto, Isamu
    Kato, Terufumi
    Kim, Young Hak
    Imamura, Fumio
    Shinkai, Masaharu
    Hodge, Rachel A.
    Uchida, Hirohiko
    Hida, Toyoaki
    CANCER SCIENCE, 2018, 109 (06): : 1930 - 1938
  • [37] Effect of simvastatin on the resistance to EGFR tyrosine kinase inhibitors in a non-small cell lung cancer with the T790M mutation of EGFR
    Hwang, Ki-Eun
    Kwon, Su-Jin
    Kim, Young-Suk
    Park, Do-Sim
    Kim, Byoung-Ryun
    Yoon, Kwon-Ha
    Jeong, Eun-Taik
    Kim, Hak-Ryul
    EXPERIMENTAL CELL RESEARCH, 2014, 323 (02) : 288 - 296
  • [38] Effect of Antibiotic Exposure on the Efficacy of EGFR TKIs in Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer (NSCLC)
    Pengnoraphat, B.
    Saichaemchan, S.
    Thambamroong, T.
    Phavirunsiri, J.
    Peechatanan, K.
    Prasongsook, N.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S623 - S623
  • [39] Management of EGFR Mutation-Positive Non-Small Cell Lung Cancer
    Lilenbaum, Rogerio A.
    Horn, Leora A.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (5.5): : 672 - 674
  • [40] Ultra-Sensitive Detection of the Pretreatment EGFR T790M Mutation in Non-Small Cell Lung Cancer Patients with an EGFR-Activating Mutation Using Droplet Digital PCR
    Watanabe, Masaru
    Kawaguchi, Tomoya
    Isa, Shun-ichi
    Ando, Masahiko
    Tamiya, Akihiro
    Kubo, Akihito
    Saka, Hideo
    Takeo, Sadanori
    Adachi, Hirofumi
    Tagawa, Tsutomu
    Kakegawa, Seiichi
    Yamashita, Motohiro
    Kataoka, Kazuhiko
    Ichinose, Yukito
    Takeuchi, Yukiyasu
    Sakamoto, Kazuhiro
    Matsumura, Akihide
    Koh, Yasuhiro
    CLINICAL CANCER RESEARCH, 2015, 21 (15) : 3552 - 3560
12345